Numerous high-risk epithelial lesions in familial breast cancer

被引:20
作者
Hoogerbrugge, N.
Buit, P.
Bonenkamp, J. J.
Ligtenberg, M. J. L.
Kiemeney, L. A.
de Hullu, J. A.
Boetes, C.
Niermeijer, M. F.
Brunner, H. G.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Med Oncol, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Surg, NL-6500 HB Nijmegen, Netherlands
[5] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Hereditary Canc Clin, Dept Radiodiagnost, NL-6500 HB Nijmegen, Netherlands
关键词
breast cancer; hereditary; BRCA; preventive mastectomy; familial; DCIS; LCIS; BRCA2 MUTATION CARRIERS; CARCINOMA IN-SITU; PROPHYLACTIC BILATERAL MASTECTOMY; GERMLINE MUTATIONS; WOMEN; PREVALENCE; PATHOLOGY; DISEASE; VALIDATION; SURGERY;
D O I
10.1016/j.ejca.2006.05.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess the occurrence of high-risk epithelial lesions in women of breast cancer families with and without a BRCA mutation. Patients and methods: Prospective study of women at very high risk of breast cancer undergoing prophylactic mastectomy (68 BRCA1 mutation carriers, 14 BRCA2 mutation carriers and 24 non-BRCA mutation carriers). Results: The prevalence of high-risk lesions is equal in women with a BRCA1 or a BRCA2 mutation, but is higher in non-BRCA mutation carriers: all lesions 43% versus 71% (P = 0.02), atypical lobular hyperplasia 26% versus 67% (p = 0.001), atypical ductal hyperplasia 17% Versus 42% (p = 0.01), lobular carcinoma-in situ 15% versus 29% (p = 0.10) and ductal carcinoma-in situ 9% versus 17% (p = 0.25). The presence of high-risk lesions is related to absence of a BRCA mutation and to age over 40 years. Conclusion: Women with an autosomal dominant family history for breast cancer, with and without a BRCA mutation are prone to develop high-risk epithelial lesions, especially over 40 years. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2492 / 2498
页数:7
相关论文
共 40 条
[1]   Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers [J].
Adem, C ;
Reynolds, C ;
Soderberg, CL ;
Slezak, JM ;
McDonnell, SK ;
Sebo, TJ ;
Schaid, DJ ;
Myers, JL ;
Sellers, TA ;
Hartmann, LC ;
Jenkins, RB .
CANCER, 2003, 97 (01) :1-11
[2]  
[Anonymous], 2004, COCHRANE DB SYST REV
[3]   The pathology of inherited breast cancer [J].
Armes, JE ;
Venter, DJ .
PATHOLOGY, 2002, 34 (04) :309-314
[4]   BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes [J].
Berry, DA ;
Iversen, ES ;
Gudbjartsson, DF ;
Hiller, EH ;
Garber, JE ;
Peshkin, BN ;
Lerman, C ;
Watson, P ;
Lynch, HT ;
Hilsenbeck, SG ;
Rubinstein, WS ;
Hughes, KS ;
Parmigiani, G .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2701-2712
[5]   Prevalence of BRCA1 and BRCA2 mutations in women diagnosed with ductal carcinoma in situ [J].
Claus, EB ;
Petruzella, S ;
Matloff, E ;
Carter, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08) :964-969
[6]  
CLAUS EB, 1994, CANCER, V73, P643, DOI 10.1002/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO
[7]  
2-5
[8]  
Domchek Susan M, 2006, J Natl Compr Canc Netw, V4, P177
[9]   RISK-FACTORS FOR BREAST-CANCER IN WOMEN WITH PROLIFERATIVE BREAST DISEASE [J].
DUPONT, WD ;
PAGE, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) :146-151
[10]  
EGAN RL, 1982, CANCER-AM CANCER SOC, V49, P1123, DOI 10.1002/1097-0142(19820315)49:6<1123::AID-CNCR2820490610>3.0.CO